Alexander Shoushtari

47PUBLICATIONS
226CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsTumour immunologyHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Jul 13, 2026
An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial.

|Jun 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

|May 13, 2026
T-Cell Clonal Expansion in Peripheral Blood Following Interventional Radiology Procedures for Metastatic Liver Cancer.

|Jan 10, 2026
Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Juan Alban, R Christopher Bowen, David A Reichstein

|Oct 03, 2025
Bridging the Gap: Incorporating Lifileucel Into Management of Advanced PD-1 Blockade Resistant Melanomas.

Melissa A Wilson, Alexander N Shoushtari

|Sep 27, 2025
Correction: Shoushtari et al. A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma. Cancers 2021, 13, 5504.

Alexander N Shoushtari, Shaheer Khan, Kimberly Komatsubara

Pageof 8

Frequent Collaborators

10 joint publications

Allison S Betof

9 joint publications

Michael Postow

7 joint publications

Jedd D Wolchok

6 joint publications

Ryan Sullivan